Liang lab group.jpg (IMAGE)

Texas Tech University Health Sciences Center

Liang lab group.jpg

Caption

TTUHSC’s Hongjun (Henry) Liang, Ph.D., received a patent that allows his lab to produce nanoantibiotics, which are novel nanoparticles that can kill some pathogens that lead to infection without affecting healthy cells.

Credit

TTUHSC

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.